Press Releases

CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.

May 25, 2017
Stem Cell Agency backs big ideas on creating a universal blood supply; regenerating injured muscles; and repairing damage caused by Alzheimer’s
May 2, 2017
CIRM Announces Leadership Transition
Apr 7, 2017
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
Mar 23, 2017
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
Mar 23, 2017
City of Hope’s Dr. Linda Malkas Appointed to Stem Cell Agency Board
Mar 17, 2017
James Harrison to Step Down as Stem Cell Agency General Counsel
Feb 23, 2017
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
Feb 8, 2017
U.C. Santa Cruz Chancellor Blumenthal Joins Stem Cell Agency Board
Jan 19, 2017
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
Dec 13, 2016
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
Dec 5, 2016
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
Nov 28, 2016
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
Nov 17, 2016
Stem Cell Agency Focuses Almost $38 Million on Colorectal Cancer, a Deadly Childhood Disorder and High Blood Pressure in the Lungs
Nov 1, 2016
Patient Advocate Leads Drive to Add Rare Diseases to CIRM’s Stem Cell Bank
Oct 24, 2016
CIRM-Funded Clinical Trial for ALS Given Go Ahead to Treat Patients
Oct 19, 2016
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
Sep 21, 2016
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
Aug 31, 2016
Stem Cell Agency Spinal Cord Injury Clinical Trial Passes Safety Hurdles
Aug 15, 2016
UC Riverside Dean Deborah Deas Joins Stem Cell Agency Board
Jul 21, 2016
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
Jun 15, 2016
CIRM Creates First of its Kind Center to Accelerate Stem Cell Development
May 19, 2016
CIRM Board Invests $7 Million in Great New Ideas and Treatment for Deadly Brain Cancer
Mar 16, 2016
CIRM Board Champions Fight Against Rare Diseases Affecting Children
Mar 6, 2016
Stem Cell Agency Honors Nancy Reagan’s Support
Feb 25, 2016
University of California, Irvine’s Dr. Howard Federoff joins CIRM Board
Feb 18, 2016
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
Jan 19, 2016
CIRM Invests $42 Million to Train Next Generation of Stem Cell Scientists
Jan 6, 2016
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
Dec 17, 2015
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future
Nov 23, 2015
Stem Cell Agency Unveils Bold New Vision for the Future
Sep 24, 2015
Stem Cell Agency Invests Almost $20 Million in Clinical Trial for Deadly Brain Cancer
Sep 1, 2015
California's stem cell bank is open for business
Aug 12, 2015
Stem Cell Agency Funded Therapy for Blinding Disease Treats First Patients
Jul 23, 2015
Stem Cell Agency Board Approves Latest Steps in CIRM 2.0, Allocates $190 million to Drive the Full Spectrum of Stem Cell Research
Jul 1, 2015
CIRM Completes Reorganization with the Appointment of Three Highly Talented Individuals to its Leadership Team
May 21, 2015
CIRM 2.0 Kicks Off With Investments in Promising Therapies for Deadly Form of Skin Cancer and Vision Destroying Disease
May 7, 2015
CIRM-Funded Therapy for Disease that Attacks Vision Gets Go Ahead for Clinical Trial
Mar 26, 2015
CIRM Awards More than $25 Million To Develop New Treatments for Disabling Disorders
Mar 3, 2015
CIRM-funded Clinical Trial Aimed at Blocking HIV/AIDS in People Gets the Go Ahead
Feb 25, 2015
CIRM-funded Program Invests More Than $11 Million in Stem Cell Genomics Research Collaborations
Jan 29, 2015
Stem Cell Agency Board Approves Almost $30 Million to Overcome Research Barriers
Jan 13, 2015
California’s Stem Cell Agency Holds Webinar on CIRM 2.0
Jan 9, 2015
CIRM Opens New On-Line Application Portal
Dec 31, 2014
California’s stem cell agency officially launches CIRM 2.0
Dec 11, 2014
Stem Cell Agency Board Approves $50 Million for CIRM 2.0, a “Radical Overhaul” of How it Drives Development of Stem Cell Treatments
Dec 1, 2014
Stem Cell Agency & Israel Announce International Collaboration to Advance Stem Cell Research
Nov 19, 2014
Poland and California Announce International Collaboration to Advance Stem Cell Research toward Cures
Nov 10, 2014
Kathy LaPorte appointed to Stem Cell Agency Board
Oct 23, 2014
Stem Cell Agency Unveils CIRM 2.0 – its Aggressive Plan to Significantly Accelerate Promising Therapies. Invests $24 Million To Create Alpha Clinic Network
Sep 17, 2014
Stem Cell Agency Invests $16 million To Fight Diabetes and Announces Plan to Launch CIRM 2.0

Pages

Media Contact

Koren Temple-Perry
Senior Director of Marketing & Communications
510-775-2314
ktemple-perry@cirm.ca.gov